| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/1995 | US5410075 Non-hygroscopic monoammonium salts of phosphonic and phosphinic acids |
| 04/25/1995 | US5410031 Nucleoside cotransporter protein cDNA |
| 04/25/1995 | US5410025 Passing polyclonal material through anion exchange column to absorb immunoglobulins, eluting low anticomplementary fraction with sodium chloride gradient and buffer under acidic conditions |
| 04/25/1995 | US5410024 Cellular antigrowth agent |
| 04/25/1995 | US5410022 Chromatic purification of a Factor VIII-containing fraction of blood, treating with a surfactant and freeze drying followed by heat treatment |
| 04/25/1995 | US5410019 Substance P analogs |
| 04/25/1995 | US5410018 Bombesin-related peptides |
| 04/25/1995 | US5409990 Useful for replacement therapy in patient suffering from hemophilia B |
| 04/25/1995 | US5409956 A sulfonylaminoalkylindan carboxylic acid or ester for treating thrombosis, vasospasm or asthma |
| 04/25/1995 | US5409927 Morpholin- and thiomorpholin-4-ylamides |
| 04/25/1995 | US5409899 Pseudopeptide compounds having anti-inflammatory activity |
| 04/25/1995 | US5409898 Synergistic composition containing beta-lactam antibiotic and cationic polypeptide |
| 04/25/1995 | US5409897 Cysteine-modified acidic fibroblast growth factor and methods of use |
| 04/25/1995 | US5409896 TGF-β composition for inducing bone growth |
| 04/25/1995 | US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof |
| 04/25/1995 | US5409894 Method of preventing balloon catheterization blood vessel damage |
| 04/25/1995 | US5409700 Pharmaceutical compositions comprising modified and unmodified plasminogen activators |
| 04/25/1995 | US5409699 Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity |
| 04/25/1995 | US5409698 Liposome immunoadjuvants containing IL-2 |
| 04/25/1995 | US5409692 Extract of fermented tea leaves |
| 04/25/1995 | EP0667783A4 Compositions and methods for preventing adhesion formation. |
| 04/25/1995 | CA1335369C Process for the purification and pasteurization of urokinase |
| 04/25/1995 | CA1335361C Thrombus-targeted complexes of plasminogen activator and fibrin fragments |
| 04/25/1995 | CA1335360C Recombinant natural killer cell activator |
| 04/25/1995 | CA1335349C Liposome composition and its production |
| 04/25/1995 | CA1335346C Method of treating erectile dysfunction |
| 04/24/1995 | EP0658096A4 Stabilized chewable antimicrobial animal foodstuff. |
| 04/20/1995 | WO1995010776A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 04/20/1995 | WO1995010632A1 Anti-paramyxovirus screening method and vaccine |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010625A1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 04/20/1995 | WO1995010623A1 Selective adenoviral mediated gene transfer into vascular neointima |
| 04/20/1995 | WO1995010614A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | WO1995010612A1 FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) |
| 04/20/1995 | WO1995010611A1 Method of inducing and maintaining neuronal cells |
| 04/20/1995 | WO1995010610A1 BETAGLYCAN POLYPEPTIDES HAVING TGF-β BINDING ACTIVITY |
| 04/20/1995 | WO1995010609A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 04/20/1995 | WO1995010608A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 04/20/1995 | WO1995010606A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | WO1995010540A1 Fas antagonists and uses thereof |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010538A1 Dna encoding the human p2u receptor and null cells expressing p2u receptors |
| 04/20/1995 | WO1995010534A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/20/1995 | WO1995010533A1 Peptides for tumour therapy |
| 04/20/1995 | WO1995010532A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010526A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | WO1995010519A1 Quinolizinone type compounds |
| 04/20/1995 | WO1995010303A1 Use of anti-idiotypic antibodies to prevent hyperacute rejection of xenografts |
| 04/20/1995 | WO1995010302A1 Cellular and serum protein anchors and conjugates |
| 04/20/1995 | WO1995010298A1 Method of contraception |
| 04/20/1995 | WO1995010297A1 Method of treating depressed reticuloendothelial system function |
| 04/20/1995 | WO1995010296A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | WO1995010295A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/20/1995 | WO1995010293A1 Compounds for medicinal use |
| 04/20/1995 | WO1995010289A1 Use of lithium compounds for treating high blood pressure |
| 04/20/1995 | WO1995010288A1 Hepatitis b virus interacts with cellular dna repair processes |
| 04/20/1995 | WO1995010273A1 Use of protein kinase c activators for the manufacture of a medicament for killing hypoxic tumor cells |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | WO1995010267A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/20/1995 | WO1995010265A1 Therapeutic delivery compositions and methods of use thereof |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2614621A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174132A1 Fas antagonists and uses thereof |
| 04/20/1995 | CA2174089A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | CA2173990A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | CA2173856A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | CA2173751A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | CA2173738A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/20/1995 | CA2173459A1 Quinolizinone type compounds |
| 04/20/1995 | CA2173322A1 Compounds for medicinal use |
| 04/20/1995 | CA2172271A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2151283A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/20/1995 | CA2118454A1 Composition for inhibiting ige production |
| 04/19/1995 | EP0648838A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) |
| 04/19/1995 | EP0648836A1 MHC class II transactivator (CIITA) and uses thereof |
| 04/19/1995 | EP0648783A1 TNF inhibitors |
| 04/19/1995 | EP0648782A1 Composition containing hematopoiesis inhibitor |
| 04/19/1995 | EP0648781A1 Nonhygroscopic crystal of aureobasidin a and production thereof |
| 04/19/1995 | EP0648780A1 Heterocyclic thrombin inhibitors |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648500A1 Cardiotrophic composition based on glycosides and beta-adrenostimulants |
| 04/19/1995 | EP0648499A1 Composition for inhibiting IgE production |
| 04/19/1995 | EP0648498A1 Physiologically active peptide compositions |
| 04/19/1995 | EP0648497A1 Emulsified preparation of aureobasidin |
| 04/19/1995 | EP0648495A2 Cation-complexed polysaccharides |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648488A1 Method to alter hairgrowth and compositions therefor |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648268A1 Therapeutic fragments of von willebrand factor |
| 04/19/1995 | EP0648264A1 Bandage for continuous application of biologicals |
| 04/19/1995 | EP0648239A1 Biocompatible polymer conjugates |
| 04/19/1995 | EP0648227A1 Improvements in or relating to neuroregeneration |
| 04/19/1995 | EP0648226A1 NATURAL HUMAN IgM ANTIBODIES |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648224A1 Conformationally restrained peptide analogs as antiplatelet agents |
| 04/19/1995 | EP0648213A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |